Dr. Khaled Aboeldahab
AI in ICU Management: A Practical, Evidence-Based Guide for Critical Care Teams
AI in ICU management means using machine-learning and language models to help critical care teams detect deterioration earlier, prioritise work, and manage beds, staff and documentation, always under clinician oversight. The idea is not new, but the evidence has matured fast, and it now tells a more cautious story than the marketing does.
This guide is written by Dr. Khaled Aboeldahab, a physician in critical and long-term care and formerly head of Long-Term Care & Rehabilitation at Global Care Hospital, Abu Dhabi. It covers what AI in the intensive care unit (ICU, or ITU in the UK) actually does, what peer-reviewed studies show about sepsis prediction, why so few tools reach the bedside, and how a unit can start safely.
In this guide
1. What does "AI in ICU management" actually mean?
2. How is AI used in the ICU today?
3. Can AI predict sepsis in the ICU? What the evidence shows
4. Why most ICU AI never reaches the bedside
5. Is AI safe in intensive care?
6. Will AI replace ICU doctors?
7. How to start using AI in an ICU: a practical checklist
8. Frequently asked questions
9. References
1. What does "AI in ICU management" actually mean?
AI in ICU management has two layers. Clinical AI predicts and supports decisions about sepsis, deterioration, ventilation and mortality risk. Operational AI helps with beds, staffing, patient flow and documentation. The main technologies are machine learning, deep learning and natural language processing, including large language models. Most tools only predict or summarise; a clinician still decides.
The phrase is often used loosely, so it helps to separate what a tool does from what it is.
Clinical vs operational AI
Clinical AI works on patient data: vital signs, laboratory results, ventilator settings, medication charts and notes. Its output is usually a risk score or an alert, such as "this patient's risk of sepsis is rising" or "this patient may be ready for a spontaneous breathing trial." Operational AI works on the unit as a system. It may forecast admissions and discharges, suggest staffing levels, or draft handover summaries. Operational errors cost time and money; clinical errors can cost lives, so the bar for clinical tools must be higher.
Predictive models vs generative AI (LLMs)
Most of the ICU literature concerns predictive models: algorithms trained on past patients to estimate the probability of a future event. They can be tested with familiar statistics such as sensitivity, positive predictive value (PPV) and the area under the receiver operating characteristic curve (AUROC). Generative AI, such as ChatGPT and other large language models, produces text. It can summarise a chart or draft a discharge letter, but it can also produce fluent statements that are wrong. The difference matters for safety: a predictive model fails by giving a wrong number, which can be audited, while a language model can fail by giving a convincing paragraph that nobody checks. If you want a wider comparison, see my piece on general AI vs medical AI.
2. How is AI used in the ICU today?
Most ICU AI research focuses on predicting outcomes and mortality, early warning of deterioration, and patient monitoring. A 2026 scoping review of 112 studies found machine learning used in 76.8% of them, but only 27.7% delivered real-time applications at the bedside. In other words, most ICU AI is still experimental rather than routine care.
The scoping review by De Cassai and colleagues in the Korean Journal of Anesthesiology (2026) is a useful map of the field. The uses below are where research activity is concentrated, but each should be read with that 27.7% figure in mind.
Early warning and deterioration detection
Early-warning models scan continuous data such as heart rate, blood pressure, respiratory rate, oxygen saturation and laboratory trends to flag patients who may deteriorate. The promise is earlier review by a senior clinician. The risk is noise: an alert that fires too often is soon ignored. This is the same trade-off seen in sepsis models, discussed in detail below.
Sepsis prediction
Sepsis is the most studied and most commercialised ICU AI use case. It is also the best example of the gap between performance in a paper and performance on a ward. The full evidence, including the Epic Sepsis Model, is in section 3.
Mechanical ventilation and weaning support
Researchers have built models to support ventilator settings, predict readiness for weaning and estimate the risk of extubation failure. These tools aim to help the team choose the right moment for a breathing trial and avoid both premature and delayed extubation. I am deliberately not quoting performance figures here, because this guide only uses numbers from sources I have checked. As with other areas, the key question for any ventilation tool is whether it has been validated outside the hospital that built it.
Mortality and outcome prediction vs APACHE and SOFA
Severity scores such as APACHE and SOFA have been used for decades to describe how sick a patient is. Machine-learning models try to improve on them by using more variables and repeated measurements over time. Better prediction does not automatically mean better care, though: a mortality score is only useful if it changes a decision. I discuss this further in AI-driven patient outcome analysis and in critical care technology and patient outcomes.
ICU rehabilitation and recovery
Recovery does not end at ICU discharge. AI is being explored to personalise early mobilisation and track functional progress after critical illness, which matters greatly for long-term care. See AI in ICU rehabilitation.
Documentation, handover and LLM assistants
Language models can draft notes, summarise long admissions and prepare handover lists. This may save clinician time, but every output must be read and corrected by the person who signs it. They are also useful for teaching, with the limits I describe in AI and junior doctor training. For literature work, specialised tools can outperform general chatbots, as discussed in AI tools for research (SciSpace).
3. Can AI predict sepsis in the ICU? What the evidence shows
Sometimes, but performance drops under realistic testing. A systematic review of 91 studies found that median AUROC fell to 0.783 when models were externally validated across the full time window. Proprietary models also generate many false alarms: a prospective validation of Epic Sepsis Model version 2 across four health systems reported PPV of only 0.13 to 0.26.
Why "accurate" models fail at the bedside
Wang and colleagues (npj Digital Medicine, 2025) reviewed 91 studies of real-time sepsis prediction models. When models were tested at fixed points shortly before sepsis onset, results looked strong: median AUROC was 0.886 at 6 hours and 0.861 at 12 hours before onset. But when models were tested across the whole hospital stay in external data, which is closer to how they are used in practice, median AUROC fell to 0.783. The review's Utility Score, which reflects clinical usefulness, fell from 0.381 to −0.164.
Two lessons follow. First, internal validation in the developer's own data flatters a model. Second, timing matters: predicting sepsis that clinicians have already recognised adds nothing.
The Epic Sepsis Model lesson
Kamran and colleagues (NEJM AI, 2024) evaluated the Epic Sepsis Model across 77,582 hospitalisations. Its AUROC was 0.62. When the authors excluded predictions made after clinicians had already recognised sepsis (for example, after cultures or antibiotics were ordered), AUROC fell to 0.47, which is no better than chance. Much of the model's apparent skill came from detecting the team's own actions, not from seeing sepsis earlier.
Version 2 and definition-dependence
Epic released an updated model. Wong and colleagues (JAMA Network Open, 2026) prospectively validated Epic Sepsis Model version 2 at four US health systems, covering 227,091 encounters. Encounter-level AUROC was 0.82 to 0.92 across sites, a clear improvement, but PPV was only 0.13 to 0.26, meaning most alerts were not sepsis and the alert burden was high.
Dutta and colleagues (JAMA Network Open, 2026) ran a sepsis model in silent deployment across nine hospitals, so its alerts were recorded but not shown to clinicians. Against the Sepsis-3 definition, AUROC was 0.89 and PPV was 11.4%, with a median lead time of 3.4 hours. Performance varied depending on which sepsis definition was used, which is a reminder that "accuracy" depends on what you measure against.
Comparison of key sepsis prediction studies
Study – Setting – AUROC – PPV / precision – Key lesson
Wang et al., npj Digit Med 2025 – Systematic review of 91 studies of real-time sepsis models – Median 0.886 (6 h) and 0.861 (12 h) pre-onset; 0.783 in full-window external validation – Not summarised as a single figure; Utility Score fell from 0.381 to −0.164 – Performance drops under realistic, external, full-window testing
Kamran et al., NEJM AI 2024 – Epic Sepsis Model, 77,582 hospitalisations – 0.62; 0.47 when predictions after clinical recognition were excluded – Not reported here – Much apparent accuracy came after clinicians had already recognised sepsis
Wong et al., JAMA Netw Open 2026 – Epic Sepsis Model v2, prospective, 4 US health systems, 227,091 encounters – 0.82–0.92 (encounter level, across sites) – 0.13–0.26 – Better discrimination, but most alerts are false positives; high alert burden
Dutta et al., JAMA Netw Open 2026 – Silent deployment, 9 hospitals – 0.89 (Sepsis-3) – 11.4% (Sepsis-3) – Median lead time 3.4 h; results vary with the sepsis definition used
A low PPV matters for antimicrobial stewardship too. Every false sepsis alert risks unnecessary cultures and antibiotics, a problem I discuss in antibiotic overuse in LTC and ICU.
4. Why most ICU AI never reaches the bedside
ICU AI research is large but immature. A 2025 JAMA Network Open review of 1,263 ICU AI studies found 74% at technology-readiness level 4 or below, only 2% reached clinical integration, and none reached full implementation. Of the studies assessed, 53% had a high risk of bias. Reliance on a few public datasets and lack of external validation are the main gaps.
This is often called the translational gap: the distance between a promising model in a paper and a tool that improves patient care.
Data monoculture and generalisability
The same JAMA Network Open review found that 46% of studies used the MIMIC database, a public dataset from a single US academic centre. The 2026 scoping review found that 24.1% of studies relied on North American public databases. A model trained on one population, one electronic health record and one set of practice habits may not work elsewhere. For hospitals in the Middle East, Africa and other regions underrepresented in these datasets, local validation is not optional.
Alert fatigue and workflow fit
A model can be accurate and still fail if it does not fit the workflow. If alerts arrive at the wrong time, go to the wrong person, or arrive too often, staff learn to dismiss them. The ESM v2 results, with PPV of 0.13 to 0.26, show how quickly alerts can outnumber true cases. Who receives the alert, what they are expected to do, and how quickly, must be decided before go-live.
Bias, equity and atypical presentations
The expert consensus published in Critical Care (2025) highlights that algorithms can miss presentations that were rare in their training data. Its example is an algorithm failing to recognise an atypical or tropical infection. Patients who differ from the training population, by geography, age, ethnicity or comorbidity, may be the ones the model serves worst. Over-reliance on a negative AI output in such a patient could delay treatment.
5. Is AI safe in intensive care?
AI can be safe in intensive care if it is validated locally, governed properly, monitored after go-live, and used to augment clinical judgement rather than replace it. A 2025 expert consensus in Critical Care recommends starting from human-AI augmentation, with intensivists leading governance. Over-trusting a negative AI output can delay treatment, so clinicians must keep thinking independently.
Human oversight and automation bias
Automation bias is the tendency to accept a machine's output without enough scrutiny. In the ICU, the dangerous version is false reassurance: a low risk score in a patient who looks unwell at the bedside. The rule should be simple. If the patient and the score disagree, believe the patient and examine again. AI output should be one input to a decision, documented as such.
Privacy and data governance
ICU data are among the most sensitive in healthcare. Before any tool is used, the unit should know where data are processed, who can access them, whether they are used to train vendor models, and how patients' rights are protected. Pasting identifiable patient information into a public chatbot is not acceptable practice. AI also has environmental and financial costs, which I discuss in the hidden costs of AI.
Regulation
Regulation of clinical AI is evolving and differs by country. Teams should read the primary texts directly, for example guidance from the US Food and Drug Administration, the European Union's AI Act, and World Health Organization guidance on AI in health, and follow their own national regulator. This guide does not summarise legal requirements, because they should be checked at the source and with your institution's legal and compliance teams.
6. Will AI replace ICU doctors?
No. AI can automate routine tasks and flag risk, but an intensivist's work includes diagnostic reasoning, weighing competing causes, ethical judgement, communicating with families and making individualised decisions. Published reviews and the 2025 expert consensus frame AI as augmentation, not replacement. What changes is the job: clinicians must learn to question and interpret model outputs.
Tasks AI does well vs tasks it cannot do
AI can help with – Clinicians remain responsible for
Watching continuous data streams for patterns – Examining the patient and integrating context
Flagging rising risk scores – Deciding whether an alert is real and what to do
Drafting notes and summaries – Checking, correcting and signing the record
Forecasting bed demand – Prioritising patients and allocating scarce resources fairly
Retrieving guideline and drug information – Weighing goals of care, ethics and family wishes
The intensivist of the near future will still examine, decide and communicate. The added skill is knowing when a model is likely to be wrong: in which patients, at what time, and against which definition.
7. How to start using AI in an ICU: a practical checklist
Start with one clear problem, such as deterioration alerts or documentation time. Check data quality, run the model silently against local outcomes before go-live, set alert thresholds that match nursing capacity, train staff, and audit PPV and alert burden every month. Do not buy a tool on the vendor's reported AUROC alone.
Data and EHR readiness
- Are vital signs, laboratory results and medications recorded electronically, on time, and in structured fields?
- Are timestamps reliable? Sepsis models depend on knowing when things happened.
- Is there a clear outcome definition (for example, Sepsis-3) that the unit agrees to measure against?
Local and silent validation
Run the model in the background before anyone sees its alerts. The Dutta et al. study is an example of silent deployment: predictions were recorded and compared against outcomes without affecting care. This tells you the local PPV, the number of alerts per day, and the lead time, before staff are exposed to the tool.
Governance, training and audit
- Name a clinical owner, ideally an intensivist, and a multidisciplinary oversight group, in line with the 2025 consensus.
- Define what each alert should trigger, and who responds.
- Train nurses and doctors on what the tool does, what it does not do, and how to report errors.
- Audit monthly: PPV, alerts per patient-day, missed cases, and any harm or near misses.
- Agree in advance the conditions under which the tool will be paused or switched off.
Low-resource and MENA settings
Many hospitals in the Middle East and North Africa, and in other low-resource settings, do not yet have complete electronic records or data teams. That does not rule out AI, but it changes the order of work. Strengthen data capture first, choose tools that can be validated locally, prefer simple and transparent models where possible, and be cautious with vendor tools trained only on North American data. Point-of-care tools such as medical calculators and validated clinical references can deliver value while the data foundation is built.
8. Frequently asked questions
How is AI used in ICU management?
AI in the ICU is mainly used to predict outcomes and mortality, give early warning of deterioration, support sepsis detection and monitor patients. It is also used operationally for bed management, staffing and documentation. However, a 2026 scoping review of 112 studies found only 27.7% delivered real-time bedside applications, so most uses remain experimental.
Can AI predict sepsis before doctors recognise it?
Sometimes, but less reliably than headline figures suggest. In a 2024 NEJM AI evaluation of the Epic Sepsis Model, AUROC fell from 0.62 to 0.47 when predictions made after clinical recognition were excluded. A silent deployment across nine hospitals reported a median lead time of 3.4 hours for Sepsis-3, with PPV of 11.4%.
How accurate is the Epic Sepsis Model?
The original Epic Sepsis Model had an AUROC of 0.62 across 77,582 hospitalisations, falling to 0.47 before clinical recognition. Version 2, prospectively validated at four US health systems, reached encounter-level AUROC of 0.82 to 0.92, but PPV was only 0.13 to 0.26, so most alerts were not sepsis and the alert burden was high.
Is AI safe to use in intensive care?
It can be, when it is validated in the local population, governed by clinicians, monitored after go-live and used to support rather than replace clinical judgement. A 2025 expert consensus in Critical Care recommends human-AI augmentation with intensivists leading governance. Over-trusting a reassuring AI output in a patient who looks unwell can delay treatment.
Will AI replace intensivists or ICU doctors?
No. AI can flag risk and automate routine tasks, but intensive care depends on examination, diagnostic reasoning, ethical judgement, family communication and individualised decisions. Reviews and expert consensus describe AI as augmentation. The role is changing rather than disappearing: ICU doctors increasingly need the skills to question and interpret model outputs.
What are the risks of using AI in clinical settings?
The main risks are false alarms and alert fatigue, missed cases in patients unlike the training data, automation bias, privacy breaches and models that perform worse outside the hospital where they were built. A 2025 review of 1,263 ICU AI studies found 53% of assessed studies had a high risk of bias, and 46% used a single public database.
Why aren't more ICU AI tools used at the bedside?
Most tools never progress beyond research. A 2025 JAMA Network Open review found 74% of ICU AI studies at technology-readiness level 4 or below, only 2% reached clinical integration and none reached full implementation. Reliance on a few public datasets, limited external validation and poor workflow fit are the main reasons.
How should a hospital start implementing AI in its ICU?
Choose one clear problem, check data quality, and run the model silently against local outcomes before staff see alerts. Set alert thresholds that match nursing capacity, name a clinical owner, train staff, and audit PPV, alert burden and missed cases every month. Never decide on a vendor's reported AUROC alone.
9. References
1. Wang Z, et al. A methodological systematic review of validation and performance of sepsis real-time prediction models. npj Digit Med. 2025;8:190. https://doi.org/10.1038/s41746-025-01587-1 (PMID 40189694)
2. Kamran F, et al. Evaluation of Sepsis Prediction Models before Onset of Treatment. NEJM AI. 2024;1(3):AIoa2300032. https://doi.org/10.1056/AIoa2300032 (PMID 42932739)
3. Wong A, et al. Multicenter Prospective Validation of an Updated Proprietary Sepsis Prediction Model. JAMA Netw Open. 2026;9(2):e260181. https://doi.org/10.1001/jamanetworkopen.2026.0181 (PMID 41758510)
4. Dutta S, et al. Performance of a Sepsis Prediction Model Across Different Sepsis Definitions. JAMA Netw Open. 2026;9(4):e265599. https://doi.org/10.1001/jamanetworkopen.2026.5599 (PMID 41945342)
5. Operationalization of AI Applications in the ICU: A Systematic Review. JAMA Netw Open. 2025;8(7):e2522866. https://doi.org/10.1001/jamanetworkopen.2025.22866 (PMID 40699572)
6. De Cassai A, et al. AI in ICUs: a scoping review addressing the translational gap. Korean J Anesthesiol. 2026;79(3):291-305. https://doi.org/10.4097/kja.251142 (PMID 41913474)
7. Implementing Artificial Intelligence in Critical Care Medicine: a consensus of 22. Crit Care. 2025. https://doi.org/10.1186/s13054-025-05532-2
8. Author credential (not clinical evidence): Wolters Kluwer. Transforming healthcare practice with UpToDate and UpToDate Lexidrug: A case study and interview from the UAE. 29 Oct 2024. https://www.wolterskluwer.com/en/expert-insights/transforming-healthcare-uptodate-case-study-interview-from-the-uae
About the author
Dr. Khaled Aboeldahab, physician in critical and long-term care. MBBS, Faculty of Medicine – Alexandria University, Egypt, November 1993; Master’s Degree in Critical Care Medicine – Alexandria University, Egypt; Advanced Diploma in Hospital Management; Master of Business Administration (MBA) – Hospital Management, Eton University; Professional Diploma in Infectious Diseases – Royal College of Physicians (RCI). Formerly head of Long-Term Care & Rehabilitation, Global Care Hospital, Abu Dhabi. Featured in a Wolters Kluwer expert insight (2024). More about the author: khaleddahab.com/about
Last updated: 29 October 2026
This guide is for education and does not replace individual medical advice.